Editas Medicine, Inc. EDIT
2.77 USD +0.10 +3.84%
As of Nov 2, 9:34 AM ET
- Open
- 2.71
- Prev close
- 2.67
- Mkt cap
- 423.73M
- Vol
- 45.66K
- Avg vol
- 2.69M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.70
- High
- 2.76
- Forward P/E
- -0.53
- Beta
- 2.01
- Short ratio
- 6.70
- Inst. own
- 70.94%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.60
- 200-d avg
- 4.55
- 1y target
- 3.67
30m chart
Chart tools
Chart is warming up
The thirty-minute interval price history for EDIT has not been loaded yet. Try again in a moment.
Altman Z-Score
-8.05 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 2
P/E -1.1×
P/S 4.5×
P/B 6.7×
P/FCF -1.1×
EV/EBITDA -0.8×
EV/Sales 2.8×
FCF Yield -91.2%
Gross Margin 100.0%
Operating Margin -245.2%
Net Margin -395.0%
ROE -586.6%
ROIC -65.6%
ROA -85.8%
Revenue 25.4%
Operating Income 60.4%
EPS (diluted) 37.5%
Free Cash Flow 24.3%
Current Ratio 3.5×
Quick Ratio 3.5×
Debt / Equity 2.8×
Net Debt / EBITDA 0.5×
Interest Coverage -16.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31